Cancer BiologybioRxivPreprint
CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovarian Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade
Mohamed Hammad, Kingsley Wu, Eslam E. Abd El-Fattah…·Chia‐en A. Chang
This paper identifies CACNA1C as a prognostic biomarker and therapeutic target in high-grade serous ovarian cancer, showing nifedipine suppresses tumor growth through calcium channel blockade.
DOI 10.64898/2026.04.19.719516